Haemato AG
Pharmaceutical company focused on specialty pharma for chronic diseases.
HAEK | F
Overview
Corporate Details
- ISIN(s):
- DE000A289VV1
- LEI:
- 529900Q3CGRYVCW7E340
- Country:
- Germany
- Address:
- Lilienthalstraße 3a, 12529 Schönefeld
- Website:
- https://haemato.de/en/start.html
- Sector:
- Wholesale and retail trade
- Industry:
- Wholesale of household goods
Description
Haemato AG is a pharmaceutical company focused on the specialty pharma market, concentrating on treatments for chronic diseases and high-priced therapies. The company's business activities include the development, acquisition, licensing, and distribution of a product portfolio that comprises innovative patent-protected medicines, biosimilars, and generics. The portfolio also extends to narcotics, including cannabis products, as well as over-the-counter (OTC) products and special cosmetics. Haemato AG's primary therapeutic areas of focus are HIV/AIDS, neurology, oncology, rheumatology, and ophthalmology.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-04-10 00:00 |
Konzernabschluss zum Geschäftsjahr vom 01.01.2023 bis zum 31.12.2023
|
German | 314.8 KB | ||
| 2025-01-15 00:00 |
Jahresabschluss zum Geschäftsjahr vom 01.01.2023 bis zum 31.12.2023
|
German | 30.6 KB | ||
| 2024-09-26 00:00 |
Jahresabschluss zum Geschäftsjahr vom 01.01.2022 bis zum 31.12.2022
|
German | 56.0 KB | ||
| 2024-02-09 00:00 |
Konzernabschluss zum Geschäftsjahr vom 01.01.2022 bis zum 31.12.2022
|
German | 343.3 KB | ||
| 2023-12-12 00:00 |
Jahresabschluss zum Geschäftsjahr vom 01.01.2021 bis zum 31.12.2021
|
German | 61.5 KB | ||
| 2023-11-30 14:14 |
HAEMATO AG: Termination of listing in the Open Market
|
English | 8.7 KB | ||
| 2023-11-16 08:21 |
HAEMATO AG publishes figures for the third quarter of 2023: Sales increase o…
|
English | 15.5 KB | ||
| 2023-11-15 19:42 |
Termination of the botulinum toxin project
|
English | 8.1 KB | ||
| 2023-10-30 00:00 |
Half-yearly financial statements 2023
|
English | 1.8 MB | ||
| 2023-10-30 00:00 |
Half-yearly financial statements 2023
|
English | 1.8 MB | ||
| 2023-08-31 09:00 |
HAEMATO AG publishes figures for the first half of 2023
|
English | 9.7 KB | ||
| 2023-06-09 00:00 |
Annual financial statements 2022
|
English | 5.9 MB | ||
| 2023-06-09 00:00 |
Annual financial statements 2022
|
English | 5.9 MB | ||
| 2023-05-31 16:34 |
HAEMATO AG with a strong start into the year 2023: Revenue increase of over 2…
|
English | 8.6 KB | ||
| 2023-05-16 17:40 |
HAEMATO AG: Dividend of EUR 1.20
|
English | 5.7 KB |
Automate Your Workflow. Get a real-time feed of all Haemato AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Haemato AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Haemato AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
